Loading Events
This event has passed.
Online Event Event Link

Medicine by Design is launching a new discussion group series to provide an opportunity for investigators and trainees from Cycle 2 projects to connect with each other, discuss overlapping interests, and share information about the development and implementation of new technologies and tools that could be applicable to multiple projects. Each session will feature two speakers from Cycle 2 projects, followed by a group discussion.

Session Title: How are stemness properties of blood relevant for cell replacement therapies?

Register now

Meeting Chair and Speaker

Dr. John Dick
Senior Scientist, Princess Margaret Cancer Centre, University Health Network

Presentation Title: Age related clonal hematopoiesis drives immune function and inflammatory processes

Cycle 2 Project Lead:
Investigating how age-related clonal hematopoiesis drives HSC stemness properties and how this leads to inflammatory diseases of the heart”

Speaker

Dr. Mathieu Lupien
Senior Scientist, Princess Margaret Cancer Centre, University Health Network

Presentation Title: Cellular heterogeneity from chromatin variants at single cell resolution

Cycle 2 Project:
Investigating how age-related clonal hematopoiesis drives HSC stemness properties and how this leads to inflammatory diseases of the heart”

About Cycle 2 Thematic Discussion Groups

Themes will focus on a technology or platform that is applicable across multiple Cycle 2 projects (e.g. single-cell sequencing, imaging, synthetic biology) or cross-cutting scientific themes (e.g. inflammation). The discussion groups will be held bi-monthly.

Each meeting will be chaired by one of our Cycle 2 principal investigators. If you or an investigator on your team are interested in chairing an upcoming session, or have a topic you would like to see discussed, please reach out to Stephanie Hume (stephanie.hume@utoronto.ca).

Go to Top